J&J pockets almost $2B with Cordis sale

Candace Stuart | | Cardiovascular Business | Interventional Cardiology

Johnson & Johnson accepted nearly $2 billion from Cardinal Health for its pioneering stent business. The acquisition of Cordis is expected to close in late 2015.

The companies announced in early March that Cardinal Health had made a binding offer for Cordis, whose Palmaz-Schatz balloon expandable stent and the Cypher sirolimus-eluting stent had contributed to the development of interventional cardiovascular care. Johnson & Johnson had until May 30 to accept the offer.

Cardinal Health sees the purchase of the Fremont, Calif.-based Cordis as part of a strategic expansion in cardiology. Cordis’ 2014 annual sales totaled about $780 million, which Cardinal Health wrote was split fairly evenly between cardiology and endovascular products.

Cardinal Health paid $1.944 billion in cash in the transaction. The original deal called for $46 million of retained net receivables as well.

In a separate statement, Johnson & Johnson reiterated that it was focusing on Biosense Webster in the electrophysiology arena and the novel oral anticoagulant rivaroxaban (Xarelto) in its pharmaceutical business.

Candace Stuart, Contributor

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup